Blood Pressure
Blood pressure is the single most impactful modifiable cardiovascular risk factor, and the one most underestimated by adults who feel fine. Cumulative lifetime exposure to elevated systolic pressure drives stroke, vascular dementia, heart failure, and kidney disease decades before symptoms appear. Optimal targets sit meaningfully below conventional guidelines, and the cost of meeting them is usually a wearable cuff and ten minutes of attention a week.
Why this biomarker matters
The relationship between systolic blood pressure and cardiovascular events is continuous and starts well below the hypertension threshold. The SPRINT trial showed a 25 percent reduction in major cardiovascular events when systolic targets were dropped from 140 to 120 mmHg in adults at elevated risk. Observational data extends this further: men with sustained systolic readings of 110 or below have substantially lower lifetime risk of stroke and dementia than those at 125–130. Elevated blood pressure damages the endothelium mechanically and accelerates atherosclerosis at every level of LDL or ApoB. It also drives left-ventricular hypertrophy and atrial remodeling that set the stage for heart failure and atrial fibrillation in later decades. The good news is that blood pressure responds well to lifestyle inputs, sodium reduction, potassium intake, aerobic training, weight loss, sleep apnea treatment, and reduced alcohol all move the needle measurably within weeks.
Weekly performance intelligence.
New studies, protocols, and optimization frameworks delivered every Monday. No fluff, no motivation quotes — only what moves the needle.